This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on August 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ Contracts

Closed

75N98026R00138Federal

Submission Closed08/18/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715

New

Federal

U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)

Solicitation # W911PT26SC001

The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.

POSTED

DEADLINE

"Provide specialized piping expertise overseeing the Craft Labor/Corrosion Control subcontractor for field modifications at KSC including but not limited to fabrication and installation of piping spool pieces, piping & tubing supports, flared & welded tub

Solicitation # 80NSSC26945986Q

NASA Shared Services Center

POSTED

DEADLINE

Scientific Data Management and Publication SupportThe Scientific Data Management and Publication Support subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, focuses on the dissemination of data, tools, and technologies for prime contractors involved in NIDCD medical research projects. The selected provider will manage resource sharing between laboratories and the NIDCD, assist in the preparation of scientific publications, and implement NIH Data Management and Sharing plans. These tasks must be executed using statistical software and secure data repositories while maintaining strict adherence to NIH cybersecurity guidelines. The primary deliverables for this engagement include the provision of disseminated data sets and the completion of published research papers. This opportunity falls under NAICS code 541715 and has a response deadline of March 5, 2027.

National Institutes Of Health

POSTED

DEADLINE

Human Temporal Bone and Fresh Ear Tissue Processing LaboratoryThis subcontract for the National Institutes of Health involves the receiving and processing of human temporal bones and fresh ear tissue to support research network projects for the NIDCD. The selected provider will be responsible for obtaining specimens from the National Hearing and Balance Organ Donor Program, processing inner and middle ear tissues, scanning slides, and summarizing donor medical records. Final deliverables include the processed specimens, high-resolution scanned images, and comprehensive annotated data. To execute these tasks, the contractor must possess specialized high-resolution slide scanning equipment and maintain strict biohazard containment protocols. Additionally, the provider is required to maintain an active IRB certification throughout the duration of the project. This effort falls under NAICS code 541715 and is managed under the Department of Health and Human Services.

National Institutes Of Health

POSTED

DEADLINE

Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

Solicitation # RFA-DC-28-002

Solicitation RFA-DC-28-002 is a Notice of Funding Opportunity from the National Institutes of Health, specifically the National Institute on Deafness and Other Communication Disorders, to establish a Coordinating Center for the NIDCD National Human Ear Resource Network. This collaborative network provides human inner and middle ear tissues to researchers for basic and clinical studies aimed at advancing the treatment of auditory and vestibular disorders. The Coordinating Center is responsible for maintaining network cohesiveness through the planning of workshops, symposia, and regular meetings, providing updates to laboratories, and managing communication with the public and scientific community regarding tissue donation. The maximum project period is five years, with a budget limit of 200,000 dollars in direct costs per year. Applicants, including for-profit organizations and small businesses, must maintain active registrations in SAM, eRA Commons, and Grants.gov. Proposals are evaluated based on the significance of the proposed center and the qualifications of the investigators, with additional reviews for human subject protections, inclusion policies, and the use of vertebrate animals. Key requirements include a structured Data Management and Sharing Plan and adherence to cybersecurity guidelines, including a 48-hour incident reporting window. The application process is entirely electronic and requires several standard PHS and SF424 forms, with a response deadline of March 5, 2027.

National Institutes Of Health

POSTED

DEADLINE

National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

Solicitation # RFA-DC-28-001

Solicitation RFA-DC-28-001 is a Notice of Funding Opportunity issued by the National Institutes of Health under the Department of Health and Human Services to support the NIDCD National Human Ear Resource Network. The objective is to maintain a collaborative network of laboratories that serve as a national technological resource, providing human inner and middle ear tissues to researchers for basic and clinical studies to advance the treatment of auditory and vestibular disorders. The scope of work includes processing human temporal bones from the National Hearing and Balance Organ Donor Program, uploading images and medical data to EarBase, sharing gene-expression data via the gEAR repository, and providing technical instruction to increase the number of skilled researchers in the field. The NIDCD intends to commit 3.6 million dollars in FY 2028 to fund up to six awards, with a maximum project period of five years. Individual awards are limited to 450,000 dollars in direct costs per year, with an additional 150,000 dollars available for specific subawards. Applications are due on March 05, 2027, and November 01, 2027, with staggered start dates ranging from July 2027 to July 2028. Evaluation is based on the experience of the investigators, the adequacy of the institutional environment, and the protection of human subjects. Applicants must maintain active SAM registration and a Unique Entity Identifier, and they must provide a Data Management and Sharing Plan and a Material Transfer Agreement. Compliance with the Cybersecurity Act of 2015 is required, including the development of an incident response plan and notification of cybersecurity incidents within 48 hours of discovery.

National Institutes Of Health

POSTED

DEADLINE

Silviculture Growth & Yield Modelling SpecialistThe Silviculture Growth and Yield Modelling Specialist subcontract supports prime contractors on projects for the Province of British Columbia's Ministry of Forests. The selected specialist will perform advanced statistical analysis and growth and yield modelling, specifically utilizing the Mixedwood Growth Model to establish stocking standards for conifer, broadleaf, mixedwood, and successional forests. A primary objective of the role is the creation of algorithms designed to project stand attributes based on data gathered from free growing surveys. Candidates must possess advanced proficiency in statistical analysis software and extensive expertise with the Mixedwood Growth Model to successfully deliver the required projection algorithms and modelled results. This opportunity was posted on October 19, 2026, with a response deadline of October 29, 2026.

POSTED

DEADLINE

Mental Health Screening Tool Array DesignThis subcontract, titled Mental Health Screening Tool Array Design, involves providing clinical content and validated screening tools to prime contractors working on Illinois State Board of Education projects. The primary objective is to develop specialized tool arrays capable of identifying childhood mental health challenges related to internalizing, externalizing, and trauma. To ensure clinical efficacy and legal compliance with Public Act 104-0032, the tools must be optimized for administration in under ten minutes. The final deliverable consists of a validated set of screening tools fully integrated into the designated platform. This project is managed under the Community Residential Services Authority for the state of Illinois.

COMRESSERVAUTH586 - Community Residential Services Authority

POSTED

DEADLINE

Notice of Correction to Award Information and Application and Submission Information for PA-27-037 "Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)"

Solicitation # NOT-OD-26-091

This notice provides corrections to the award and application information for the Predoctoral to Postdoctoral Transition Award (Parent F99/K00), specifically for solicitation NOT-OD-26-091 issued by the National Institutes of Health. The primary updates involve the removal of Kirschstein-NRSA support period limitations. Eligible individuals may now receive up to five years of aggregate support, consisting of up to two years at the F99 predoctoral level and up to three years at the K00 postdoctoral level. Additionally, the notice clarifies that a Certification Letter is no longer required for these applications, and corresponding instructions have been removed from the SF424(R&R) Other Project Information section. These changes are effective for the application due date of August 8, 2026. For further inquiries, the Division of Biomedical Research Workforce serves as the primary point of contact.

National Institutes Of Health Office Of The Director

POSTED

DEADLINE

Notice of NIBIB Participation in PA-27-037: Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)

Solicitation # NOT-EB-26-005

The National Institute of Biomedical Imaging and Bioengineering is joining the Predoctoral to Postdoctoral Transition Award (Parent F99/K00), effective for applications received on or after December 08, 2026. This funding opportunity is designed for researchers transitioning from predoctoral to postdoctoral training, provided that clinical trials are not involved. All submitted applications must align with the specific missions of the participating Institutes and Centers. This update expands the list of participating organizations and agency contacts to include the National Institute of Biomedical Imaging and Bioengineering and its Chief Grants Management Officer. The award is supported by a wide array of National Institutes of Health offices and centers, including the National Cancer Institute and the National Institute on Aging, among others. All other terms and conditions of the original notice of funding opportunity remain unchanged.

National Institute Of Biomedical Imaging And Bioengineering

POSTED

DEADLINE

Notice of FIC Participation in PA-26-002 "NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)"

Solicitation # NOT-TW-26-002

The Fogarty International Center is participating in the NIH Collaborative International Research Project, identified as PA-26-002. This funding opportunity is effective for applications submitted on or after January 25, 2027. The program is designed for collaborative international research projects and allows for optional clinical trials. A wide array of NIH Institutes and Centers are participating organizations, and applications must align with their specific missions. Additionally, the Office of Research on Women's Health, the INCLUDE Project, and the Office of Data Science Strategy may provide co-funding for assigned applications. All other terms and conditions of the original notice of funding opportunity remain unchanged.

POSTED

DEADLINE

Thermal Performance & Dielectric Testing LaboratoryThis subcontract opportunity is for a Thermal Performance and Dielectric Testing Laboratory to provide independent testing and validation services for prime contractors supporting USAF AFLCMC/WAR F-22 cooling fluid projects. The selected provider will be responsible for evaluating low-temperature viscosity, high-temperature stability, and dielectric strength utilizing specialized equipment such as viscosity meters and stability chambers. The final deliverables for this engagement include comprehensive technical test reports and performance validation data. To be eligible, the contractor must be a domestic U.S. company and hold ISO/IEC 17025 accreditation. The work is associated with NAICS code 541715 and will be performed at Wright Patterson AFB. Interested parties must submit their responses by November 3, 2026.

FA8611 Aflcmc Wauk F22

POSTED

2 days ago

DEADLINE

in 14 days

AI Contract Overview

The National Institute on Neurological Disorders and Stroke plans to extend the ordering period of four existing multiple-award Indefinite Quantity Indefinite Delivery contracts under the Pharmacology and Toxicology for Therapeutics Program by two years, from September 12, 2026, to September 12, 2028. These contracts are held by SRI International, Southern Research, IIT Research Institute, and the University of Illinois Chicago, and they support critical preclinical pharmacology and toxicology studies essential for advancing therapeutic candidates toward FDA Investigational New Drug applications. The work includes in vivo pharmacokinetics, acute and chronic toxicity evaluations, safety pharmacology, genotoxicity and carcinogenicity assessments, and in vitro ADMET assays, serving both the NIH Blueprint Neurotherapeutics Network and external NIH-funded projects. The modification is authorized under 41 U.S.C. 3304(a)(1) and follows RFO procedures for sole-source actions, as no other sources are deemed capable of meeting the agency’s requirements. The effort is classified under NAICS code 541715 with a size standard of 1,000 employees and is governed by Executive Order 14275 and OMB Memorandum M-25-26. Interested parties may submit capability statements, express interest, or lodge objections by August 18, 2026, at 3:00 p.m. Eastern Time, electronically to Sneha Singh at sneha.singh@nih.gov, referencing solicitation number 75N98026R00138. All respondents must have an active SAM registration with a valid Unique Entity Identifier and Taxpayer Identification Number, along with a certified business size statement. The government will evaluate submissions to determine whether to proceed with the non-competitive modification or initiate a new competitive procurement. No formal competitive bidding is being requested, and the decision to extend the contracts rests entirely at the discretion of the government. The requirement is not being fulfilled under commercial item acquisition authorities, but responders may still indicate if they can satisfy the need with commercial solutions.

General Info

Extend four sole-source contracts for preclinical pharmacology and toxicology studies through September 2028.

Agency

Department Of Health And Human Services → National Institutes Of Health Nida

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Bethesda, MD, USA

Set-Aside

NONE

Documents

Notice of Intent to Award Modifications for PTTP Contract Extension

presolicitation

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedAug 3

Presolicitation

Response DeadlineAug 18

Deadline has passed

Submission Closed

08/18/2026, 07:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida

Contacts1 person available

OfficeBethesda, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida

Office AddressBethesda, MD, 20892, USA

Contacts

Sneha Singh

contact@example.gov

Full Description

INTRODUCTION

PURSUANT TO RFO SUBPART 5.101- PRESOLICITATION NOTICE, THIS IS A NOTICE OF A PROPOSED CONTRACT ACTION.

THIS IS A NOTICE OF INTENT TO AWARD MODIFICATIONS TO EXTEND THE ORDERING PERIOD BY TWO (2) YEARS UNDER THE FOLLOWING CONTRACT NOS:

HHSN271201600006i - SRI International

HHSN27120160007i - Southern Research

75N95021D00026 - IIT Research Institute (IITRI)

75N95022D00026 - University of Illinois Chicago

The National Institute on Neurological Disorders and Stroke (NINDS) intends to modify the multiple-award Indefinite Quantity Indefinite Delivery (IDIQ) contracts under the Pharmacology and Toxicology for Therapeutics Program (PTTP). These contracts serve as part of the NIH Blueprint Neurotherapeutics Network (BPN) and are also utilized for individual development projects outside of the Blueprint Network. These services are a critical component of the BPN drug development infrastructure, supporting all preclinical pharmacology and toxicology testing needed to inform lead discovery and the selection of a clinical candidate, as well as comprehensive studies needed for regulatory filings such as FDA Investigational New Drug (IND) applications to allow for clinical evaluation of the candidates. This modification will extend the ordering period as denoted in IDIQ contract clause FAR 52.216-18, Ordering (AUG 2020), to be extended September 12, 2026, to September 12, 2028.

The extension will allow the four existing IDIQ holders to continue supporting BPN and other NINDS initiatives - including pharmacokinetic (PK), non-GLP, and GLP-IND-enabling studies - while the PTTP requirement is recompeted and a new IDIQ contract is awarded.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The requirement is classified under NAICS code is 541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), with a size standard of 1,000 employees.

REGULATORY AUTHORITY

The resultant modification will include all the applicable provisions and clauses of the RFO initiative, in accordance with Executive Order 14275 and OMB Memorandum M-25-26.

STATUTORY AUTHORITY

This modification is conducted under the authority of 41 U.S.C. 3304(a)(1) and in accordance with RFO – FAR 6.103-1- Only one responsible source and no other supplies or services will satisfy agency requirements.

DESCRIPTION

Background

The National Institute of Neurological Disorders and Stroke (NINDS) and the

NIH Blueprint Neurotherapeutics Network (BPN) have established a

‘virtual pharma’ network of contract service providers and consultants with

extensive industry experience to enable therapeutic (e.g., small molecule,

peptide, biologic) development in the NIH research community. The Network,

similar NINDS and NIH programs offer researchers access to a range of industry style therapeutic development services and expertise, including medicinal

chemistry, IND-enabling studies, and Phase I clinical trial infrastructure, with the

goal of supporting efforts to advance compounds successfully through Phase I

clinical testing. Projects may utilize some or all of the BPN infrastructure. The

PTTP contract will support all preclinical pharmacology and toxicology testing

needed to inform lead discovery, the selection of a clinical candidate, and

comprehensive studies needed for regulatory filings, such as an Investigational

New Drug (IND) application to the FDA, to allow for clinical evaluation of the

candidates. This contract will serve as part of the NIH Blueprint Neurotherapeutics

Network and will also be utilized for individual development projects outside of the

Blueprint Network.

Scope and Objectives

The goal of the PTTP is to assess the pharmacokinetics, toxicology and safety of

promising candidates to support their eventual use as therapeutics. It is anticipated

that NIH-approved samples will be submitted from a variety of sources including

NIH-funded research programs, pharmaceutical companies, biotechnology

companies, or other sources. Pharmacology, toxicology and safety data generated

from this program may be used by investigators in support of an Investigational

New Drug (IND) application.

Studies to be performed may include, but are not limited to:

• Development and validation of the analytical methods for quantitating

drug/biologic concentrations in dosing solutions, biological fluids, and

tissues, as required

• In vivo pharmacokinetic studies through various routes of administration

• Preclinical acute toxicity evaluations on lead compounds or therapeutics

• Subacute, subchronic, and/or long-term toxicity evaluations in rodents

and non-rodent species

• Safety Pharmacology Studies in rodent and non-rodent species (e.g.,

cardiovascular, pulmonary, CNS)

• Genotoxicity assessments using a battery of appropriate assays and

carcinogenicity assessments

• In vitro predictive ADMET assays, including metabolic stability studies,

hepatotoxicity, permeability studies, cytochrome P450 assays, plasma

protein binding, and cytotoxicity assay

Period of Performance

As a result of this modification, the ordering period of the IDIQ will be extended by two (2) years, from September 12, 2026, to September 12, 2028.

Closing Statement

This synopsis is not a request for competitive proposals and the government is not committed to award a contract pursuant to this announcement. However, interested parties may respond by identifying their interest, submitting capability statements, or submitting objections to the proposed contract modification. The government will consider responses, however, a determination by the government to proceed with the proposed contract modification is solely within the discretion of the government.

Any potential offeror must have an active registration in the System for Award Management (SAM), housed at www.sam.gov. In addition, the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and the certification of business size must be included in the response.

A determination by the government not to compete these requirements based upon responses to this notice is solely within the discretion of the government. The information received will normally be considered solely for the purposes for determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

Based upon market research, the government is not using RFO Part 12, Acquisition of Commercial Products and Commercial Services, to fulfill this requirement. However, interested persons may identify to the Contracting Officer their interest and capability to satisfy the Government’s requirement with a commercial item within 15 days of this notice.

All responses must be received by August 18, 2026, at 3:00 pm Eastern Time. Responses must be submitted electronically to Sneha Singh, Contacting Officer, at sneha.singh@nih.gov. Please reference notice, 75N98026R00138 in any responses or inquiries.